Article
Molecular principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of…
bioRxiv · 2023 · Carolyn Shembrey
Key facts
| Title | Molecular principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision |
|---|---|
| First author | Carolyn Shembrey |
| Journal | bioRxiv |
| Published | Sep 26, 2023 |
| DOI | 10.1101/2023.09.26.557083 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIT, NDS, NJT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1